Acute myeloid leukemia in the elderly: Assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group Study

Catherine P. Leith, Kenneth J. Kopecky, John Godwin, Thomas McConnell, Marilyn L. Slovak, I. Ming Chen, David R. Head, Frederick R. Appelbaum, Cheryl L. Willman

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Acute myeloid leukemia in the elderly: Assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group Study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds